Next Article in Journal / Special Issue
Multifilm Mass Transfer and Time Constants for Mass Transfer in Food Digestion: Application to Gut-on-Chip Models
Previous Article in Journal
Anti-Tumour Activities from Secondary Metabolites and Their Derivatives in Bryophytes: A Brief Review
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Opinion

Does Intestine Morphology Still Have Secrets to Reveal? A Proposal about the “Ghost” Layer of the Bowel

1
Department of Biomedicine, Neuroscience and Advanced Diagnostics, University of Palermo, 90127 Palermo, Italy
2
Euro-Mediterranean Institute of Science and Technology, 90139 Palermo, Italy
*
Author to whom correspondence should be addressed.
Appl. Biosci. 2022, 1(1), 95-100; https://doi.org/10.3390/applbiosci1010006
Submission received: 13 May 2022 / Revised: 1 June 2022 / Accepted: 6 June 2022 / Published: 7 June 2022
(This article belongs to the Special Issue Feature Papers for the Inaugural Issue of Applied Biosciences)

Abstract

:
In this brief Opinion paper, the term “muco-microbiotic layer” is introduced to describe the innermost layer of the intestinal wall. This layer may contribute not only to the overall health of the bowel, but also to that of extraintestinal organs. Its constituents, in terms of soluble molecules and nanovesicles, need to be studied further. Moreover, one can hypothesize the existence of an analogous layer in other organs, such as the airways or some parts of the genital tracts. Further studies on it are needed.

1. An Anatomical Introduction

In Anatomy and Histology treatises, within the chapters on the structure of the intestine, little space is left to uncertainty and the readers’ imagination, whether they be young students or expert scientists: the intestinal wall—just like the other organs of the alimentary canal—consists of four overlapping tunicae as if they were four soft cylinders inserted one inside the other, which have been named—from the inner to the outer—“mucosa”, “submucosa”, “muscularis propria” and “adventitia” (the latter incorporated in the submesothelial connective tissue of the serosa, the peritoneum, when present) [1].
Particular attention is given to the mucosa, usually defined as the innermost tunic, which is, in turn, composed of three layers, all of the equal importance: the epithelium (the layer facing the lumen), whose cellular elements morpho-functionally better characterize the two portions into which it is divided the intestine (i.e., small and large); the lamina propria, containing not only the blood vessels for tissue trophism but also lymphatics, immune cells, undifferentiated mesenchymal cells, nerve fibers, and other cells and structures that harbor—in some parts—glandular introflexions derived from the lining epithelium; and, last but not least, the muscularis mucosae, a thin bundle of smooth muscle fiber cells, which has the dual purpose of protecting the submucosa (more richly vascularized and innervated than the lamina propria) from chemical or traumatic insults that can affect the more abluminal layers on one hand, and to physically separate the two connective layers of the lamina propria and submucosa, thus actively participating in the creation of two different microenvironments, on the other [1].
The concept of the microenvironment becomes more relevant as our knowledge of the constituents of the human body increases, since it is now clear that cells can differentiate, perform metabolic functions, communicate with each other, and cease (more or less voluntarily) their existence based on the chemical–physical stimuli provided by the environment [2].

2. The Microbiota and Its Microenvironment

In the last few decades, a further constituent of the intestine structure has emerged in the scientific literature: the microbiota, that is, the array of all living elements, bacterial and not, that colonize our intestine, not having been generated together with it—therefore not sharing their genetic heritage with the cells of the individual who hosts them—but having reached a saprophytic balance with it [3]. The constituents of microbiotic flora are presented in Figure 1 and Table 1, Table 2 and Table 3.
The microbiota is defined by some—improperly, from a strictly morphological point of view—as “the organ within the organ”; instead, we would like to redefine and reframe it in a morpho-functionally more appropriate way in the short text that follows. To do this, we have to start by correlating the “morphology” with the “pathophysiology”. Thus, please forgive us for the slightly pedantic nature of the following paragraphs.
The human body can be subdivided into apparatuses (or systems), which can be split into organs, each formed of tissues, in turn composed of cells, each specialized for their function (just remember how different they are, morpho-functionally, not just a neuron from a muscle cell, but also an absorbing epithelial cell from a secreting one) [4].
The alteration of cellular differentiation triggers the disorganization of the tissue, which, in turn, causes organ malfunction, causing the organism to display signs of illness. Physicians, through the knowledge of topographical anatomy, are called to identify the organ and/or the anatomical area affected by the disease, using semiotic tools (physical and instrumental); the knowledge of the structures of the human body permits them to identify where those natural mechanisms regulating cell differentiation, tissue homeostasis and organ remodeling (all phenomena that continue throughout life, both pre- and postnatally, including not only infancy and adolescence but also tissue senescence and organ meiopragia later in life) are malfunctioning [5].
Table 1. The Prokaryotic kingdom and their phyla in the human microbiota. The percentages derive from literature data.
Table 1. The Prokaryotic kingdom and their phyla in the human microbiota. The percentages derive from literature data.
Procaryota
KingdomsPhylumGenus(%)References
BacteriaFirmicutesLactobacillus5%[6,7,8,9,10,11,12]
Faecalibacterium5%[12]
Halomonas3%[12]
Clostridium3%[12]
Ruminococcus7%[12]
Roseburia4%[12]
Streptococcus2%[12]
Others21%[12]
BacteroidetesBacteroides19%[6,7,8,9,10,11,12,13]
Others2%[12]
ActinobacteriaBifidobacterium4%[9,12,14]
Others1%[12]
ProteobacteriaEscherichia5%[10,13]
Shigella2%[10]
Others9%[13]
SpirochaetesBrachyspira3%[12]
Others2%[12]
OthersOthers2%[11]
ArcheaEuryarchaeotaHalobacteria2%[15]
Table 2. The Eukaryotic kingdom and their phyla in the human microbiota. The percentages derive from literature data.
Table 2. The Eukaryotic kingdom and their phyla in the human microbiota. The percentages derive from literature data.
Eukaryota
PhylumGenus(%)References
AscomycotaDebaryomycetaceae13%[16,17,18]
Dipodascaceae14%[17]
Saccharomycetaceae13%[17]
BasidiomycotaTremellomycetes20%[16]
Malasseziaceae20%[19]
MucorimycotaFusicatenibacter5%[17]
Aspergiullus5%[19]
Table 3. The Virii kingdom in the human microbiota. The percentages derive from literature data.
Table 3. The Virii kingdom in the human microbiota. The percentages derive from literature data.
Virii
PhylumGenus(%)References
CaudoviralesSiphoviridae20%[11,20,21,22,23]
Myoviridae20%[17,22,23]
Podoviridae20%[17,22,23]
Others40%[11,22,23]
The identification of “breakdown” at the cellular level can lead to targeted therapy (sometimes just lifestyle changes are enough; other times, drug therapy may be necessary; and, in extremis, surgical intervention could be inevitable for the demolition and eventual reconstruction of the irremediably sick part), and the efforts of the biomedical and bioengineering community are concentrated above all on developing such therapy protocols.
It now seems certain that the microbiota is involved in many intestinal pathologies, therefore implying that it can transform itself from a combination of commensal germs to a mix of pathogens under certain conditions and for causes that are not yet fully understood [24,25,26,27]. What mainly affects the health of the microbiota is certainly the microenvironment in which we live and, in the first place, our diet: what passes through the intestinal lumen throughout our existence. However, to better understand how and why the microbiota is altered and, above all, how and why this alteration affects not only intestinal homeostasis but also that of other tissues physically distant from it, the context of its microenvironment, i.e., the mucus that lines the epithelial surface of the intestine and in which the microbiota is contained, must be contemplated [28].

3. The Muco-Microbiotic Layer

Mucus and microbiota form a morpho-functional layer, the biological elements of the microbiota being comparable to a “cellular component”, and the mucus to the “matrix” in which not only these cells reside, but also in which their products—both soluble molecules (proteins, lipids, etc.) and nanovesicles (for example, the “outer membrane vesicles”, OMV, of prokaryotic origin, equivalent to the exosomes produced by eukaryotic cells)—are released [28,29].
Figure 2 shows, schematically, the composition of the muco-microbiotic (MuMi) layer with its main constituents. Why has the MuMi layer been ignored until now, and why has it not yet been described in anatomy and histology books? This is probably due to the fact that widely used histochemical stains contain alcohol, which solubilizes the mucus by sweeping it away along with the microbiota. Therefore, in histological sections, neither of these two components are visible, if not in minute traces, and this has led scientists to dismiss it as a physiological constituent of our bodies.
The MuMi layer is therefore located in the bowel internally to the mucosa, representing the innermost “fifth layer” (or the first one) of the intestinal wall; the alterations of the mucous matrix can cause a qualitative and quantitative modification of the populations of germs that housed in it, and vice versa [28,29]. In addition, the intense traffic of soluble products and nano-vesicles mutually influence human and microbiotic cells; the increase in pathogenic bacteria generates, for example, a disturbance in the microenvironment of the lamina propria, triggering or perpetuating inflammatory processes; and since the nanovesicles (both human and bacterial) can easily reach both the bloodstream and the lymphatic one, the well-being of our intestinal MuMi layer can affect the homeostasis of extra-intestinal tissues, thus compromising the function of other organs, including the liver, lung, heart, and brain, just to mention the most important ones considering the anatomical progression of the blood mass originating from the abdominal splanchnic district [28].

4. Conclusions

Based on the consideration reported above, the existence of the MuMi layer, in our modest opinion, should not only no longer be ignored, but must also be investigated (also in other anatomical districts, e.g., the airways or some genital tract organs) in order to characterize, from a morpho-molecular point of view, its constituents and the mechanisms that fine-tune all the related physiological and pathophysiological events.
Limiting our conclusion to the bowel, if the Hippocratic axiom “we are what we eat” is still true, and if it is correct to think that the health of our body depends, in the first instance, on the health of our intestine, omitting the observations of molecular phenomena that occur in this layer from scientific reasoning—as well as from scientific protocols—would undermine the achievement of better knowledge on human health.

Author Contributions

Conceptualization, F.C. and F.B.; methodology, S.B. and L.P.; software, S.B. and D.S.; writing—original draft preparation, F.C., S.B. and L.P.; writing—review and editing, D.S. and F.B. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Gartner, L. Textbook of Histology, 5th ed.; Elsevier: Amsterdam, The Netherlands, 2020. [Google Scholar]
  2. Jiang, T.; Yang, T.; Chen, Y.; Miao, Y.; Xu, Y.; Jiang, H.; Yang, M.; Mao, C. Emulating interactions between microorganisms and tumor microenvironment to develop cancer theranostics. Theranostics 2022, 12, 2833–2859. [Google Scholar] [CrossRef] [PubMed]
  3. Suzuki, T.A.; Ley, R.E. The role of the microbiota in human genetic adaptation. Science 2020, 370, eaaz6827. [Google Scholar] [CrossRef] [PubMed]
  4. Standring, S. Gray′s Anatomy. The Anatomical Basis of Clinical Practice, 42nd ed.; Elsevier: Amsterdam, The Netherlands, 2020. [Google Scholar]
  5. Campanella, C.; Caruso Bavisotto, C.; Logozzi, M.; Marino Gammazza, A.; Mizzoni, D.; Cappello, F.; Fais, S. On the Choice of the Extracellular Vesicles for Therapeutic Purposes. Int. J. Mol. Sci. 2019, 20, 236. [Google Scholar] [CrossRef] [Green Version]
  6. Bäckhed, F.; Ley, R.E.; Sonnenburg, J.L.; Peterson, D.A.; Gordon, J.I. Host-bacterial mutualism in the human intestine. Science 2005, 307, 1915–1920. [Google Scholar] [CrossRef] [Green Version]
  7. Eckburg, P.B.; Bik, E.M.; Bernstein, C.N.; Purdom, E.; Dethlefsen, L.; Sargent, M.; Gill, S.R.; Nelson, K.E.; Relman, D.A. Diversity of the Human Intestinal Microbial Flora. Science 2005, 308, 1635–1638. [Google Scholar] [CrossRef] [Green Version]
  8. Kim, J.Y.; Whon, T.W.; Lim, M.Y.; Kim, Y.B.; Kim, N.; Kwon, M.S.; Kim, J.; Lee, S.H.; Choi, H.J.; Nam, I.H.; et al. The human gut archaeome: Identification of diverse haloarchaea in Korean subjects. Microbiome 2020, 8, 114. [Google Scholar] [CrossRef] [PubMed]
  9. King, C.H.; Desai, H.; Sylvetsky, A.C.; LoTempio, J.; Ayanyan, S.; Carrie, J.; Crandall, K.A.; Fochtman, B.C.; Gasparyan, L.; Gulzar, N.; et al. Baseline human gut microbiota profile in healthy people and standard reporting template. PLoS ONE 2019, 14, e0206484. [Google Scholar] [CrossRef] [Green Version]
  10. Lin, A.; Bik, E.M.; Costello, E.K.; Dethlefsen, L.; Haque, R.; Relman, D.A.; Singh, U. Distinct distal gut microbiome diversity and composition in healthy children from Bangladesh and the United States. PLoS ONE 2013, 8, e53838. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  11. Nayfach, S.; Páez-Espino, D.; Call, L.; Low, S.J.; Sberro, H.; Ivanova, N.N.; Proal, A.D.; Fischbach, M.A.; Bhatt, A.S.; Hugenholtz, P.; et al. Metagenomic compendium of 189,680 DNA viruses from the human gut microbiome. Nat. Microbiol. 2021, 6, 960–970. [Google Scholar] [CrossRef]
  12. Zhang, Q.; Zhao, H.; Wu, D.; Cao, D.; Ma, W. A comprehensive analysis of the microbiota composition and gene expression in colorectal cancer. BMC Microbiol. 2020, 20, 308. [Google Scholar] [CrossRef] [PubMed]
  13. Manrique, P.; Dills, M.; Young, M.J. The Human Gut Phage Community and Its Implications for Health and Disease. Viruses 2017, 9, 141. [Google Scholar] [CrossRef] [Green Version]
  14. Miller, T.L.; Wolin, M.J. Methanogens in human and animal intestinal Tracts. Syst. Appl. Microbiol. 1986, 7, 223–229. [Google Scholar] [CrossRef]
  15. Hoffmann, C.; Dollive, S.; Grunberg, S.; Chen, J.; Li, H.; Wu, G.D.; Lewis, J.D.; Bushman, F.D. Archaea and fungi of the human gut microbiome: Correlations with diet and bacterial residents. PLoS ONE 2013, 8, e66019. [Google Scholar] [CrossRef] [Green Version]
  16. Li, J.; Chen, D.; Yu, B.; He, J.; Zheng, P.; Mao, X.; Yu, J.; Luo, J.; Tian, G.; Huang, Z.; et al. Fungi in Gastrointestinal Tracts of Human and Mice: From Community to Functions. Microb. Ecol. 2018, 75, 821–829. [Google Scholar] [CrossRef]
  17. Raimondi, S.; Amaretti, A.; Gozzoli, C.; Simone, M.; Righini, L.; Candeliere, F.; Brun, P.; Ardizzoni, A.; Colombari, B.; Paulone, S.; et al. Longitudinal Survey of Fungi in the Human Gut: ITS Profiling, Phenotyping, and Colonization. Front. Microbiol. 2019, 10, 1575. [Google Scholar] [CrossRef] [Green Version]
  18. Kühbacher, T.; Ott, S.J.; Helwig, U.; Mimura, T.; Rizzello, F.; Kleessen, B.; Gionchetti, P.; Blaut, M.; Campieri, M.; Fölsch, U.R.; et al. Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis. Gut 2006, 55, 833–841. [Google Scholar]
  19. Underhill, D.M.; Iliev, I.D. The mycobiota: Interactions between commensal fungi and the host immune system. Nat. Rev. Immunol. 2014, 14, 405–416. [Google Scholar] [CrossRef]
  20. Abeles, S.R.; Pride, D.T. Molecular bases and role of viruses in the human microbiome. J. Mol. Biol. 2014, 426, 3892–3906. [Google Scholar] [CrossRef]
  21. Mayneris-Perxachs, J.; Castells-Nobau, A.; Arnoriaga-Rodríguez, M.; Garre-Olmo, J.; Puig, J.; Ramos, R.; Martínez-Hernández, F.; Burokas, A.; Coll, C.; Moreno-Navarrete, J.M.; et al. Caudovirales bacteriophages are associated with improved executive function and memory in flies, mice, and humans. Cell Host Microbe 2022, 30, 340–356.e348. [Google Scholar] [CrossRef]
  22. Zhang, T.; Breitbart, M.; Lee, W.H.; Run, J.Q.; Wei, C.L.; Soh, S.W.; Hibberd, M.L.; Liu, E.T.; Rohwer, F.; Ruan, Y. RNA viral community in human feces: Prevalence of plant pathogenic viruses. PLoS Biol. 2006, 4, e3. [Google Scholar] [CrossRef] [Green Version]
  23. Scarpellini, E.; Ianiro, G.; Attili, F.; Bassanelli, C.; De Santis, A.; Gasbarrini, A. The human gut microbiota and virome: Potential therapeutic implications. Dig. Liver Dis. Off. J. Ital. Soc. Gastroenterol. Ital. Assoc. Study Liver 2015, 47, 1007–1012. [Google Scholar] [CrossRef] [Green Version]
  24. Bellavia, M.; Tomasello, G.; Romeo, M.; Damiani, P.; Lo Monte, A.I.; Lozio, L.; Campanella, C.; Marino Gammazza, A.; Rappa, F.; Zummo, G.; et al. Gut microbiota imbalance and chaperoning system malfunction are central to ulcerative colitis pathogenesis and can be counteracted with specifically designed probiotics: A working hypothesis. Med. Microbiol. Immunol. 2013, 202, 393–406. [Google Scholar] [CrossRef] [Green Version]
  25. Untersmayr, E.; Brandt, A.; Koidl, L.; Bergheim, I. The Intestinal Barrier Dysfunction as Driving Factor of Inflammaging. Nutrients 2022, 14, 949. [Google Scholar] [CrossRef] [PubMed]
  26. Stolfi, C.; Maresca, C.; Monteleone, G.; Laudisi, F. Implication of Intestinal Barrier Dysfunction in Gut Dysbiosis and Diseases. Biomedicines 2022, 10, 289. [Google Scholar] [CrossRef] [PubMed]
  27. Nandwana, V.; Nandwana, N.K.; Das, Y.; Saito, M.; Panda, T.; Das, S.; Almaguel, F.; Hosmane, N.S.; Das, B.C. The Role of Microbiome in Brain Development and Neurodegenerative Diseases. Molecules 2022, 27, 3402. [Google Scholar] [CrossRef]
  28. Cappello, F.; Rappa, F.; Canepa, F.; Carini, F.; Mazzola, M.; Tomasello, G.; Bonaventura, G.; Giuliana, G.; Leone, A.; Saguto, D.; et al. Probiotics Can Cure Oral Aphthous-Like Ulcers in Inflammatory Bowel Disease Patients: A Review of the Literature and a Working Hypothesis. Int. J. Mol. Sci. 2019, 20, 5026. [Google Scholar] [CrossRef] [Green Version]
  29. Cappello, F.; Mazzola, M.; Jurjus, A.; Zeenny, M.N.; Jurjus, R.; Carini, F.; Leone, A.; Bonaventura, G.; Tomasello, G.; Bucchieri, F.; et al. Hsp60 as a Novel Target in IBD Management: A Prospect. Front. Pharmacol. 2019, 10, 26. [Google Scholar] [CrossRef] [PubMed]
Figure 1. The microbiotic flora. The microbiota is mainly made up of prokaryotic elements (90%) and, in a lesser extent, of eukaryotic (9%) and virii (1%) species. See Table 1, Table 2 and Table 3 for more information about its composition.
Figure 1. The microbiotic flora. The microbiota is mainly made up of prokaryotic elements (90%) and, in a lesser extent, of eukaryotic (9%) and virii (1%) species. See Table 1, Table 2 and Table 3 for more information about its composition.
Applbiosci 01 00006 g001
Figure 2. The muco-microbiotic (MuMi) layer. This figure shows, schematically, the MuMi layer, its main constituents (in terms of microbiotic elements and nanovesicles) and its relationships with the underlying mucosal components, i.e., epithelial cells and lamina propria. Whereas nanovesicles, either human- and microbiota-derived ones, can easily reach the lamina propria (in turn contributing to determine its microenvironment), the muscularis mucosae represents a wall between the connective tissue of the lamina propria and that of the submucosa (not shown).
Figure 2. The muco-microbiotic (MuMi) layer. This figure shows, schematically, the MuMi layer, its main constituents (in terms of microbiotic elements and nanovesicles) and its relationships with the underlying mucosal components, i.e., epithelial cells and lamina propria. Whereas nanovesicles, either human- and microbiota-derived ones, can easily reach the lamina propria (in turn contributing to determine its microenvironment), the muscularis mucosae represents a wall between the connective tissue of the lamina propria and that of the submucosa (not shown).
Applbiosci 01 00006 g002
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Cappello, F.; Saguto, D.; Burgio, S.; Paladino, L.; Bucchieri, F. Does Intestine Morphology Still Have Secrets to Reveal? A Proposal about the “Ghost” Layer of the Bowel. Appl. Biosci. 2022, 1, 95-100. https://doi.org/10.3390/applbiosci1010006

AMA Style

Cappello F, Saguto D, Burgio S, Paladino L, Bucchieri F. Does Intestine Morphology Still Have Secrets to Reveal? A Proposal about the “Ghost” Layer of the Bowel. Applied Biosciences. 2022; 1(1):95-100. https://doi.org/10.3390/applbiosci1010006

Chicago/Turabian Style

Cappello, Francesco, Dario Saguto, Stefano Burgio, Letizia Paladino, and Fabio Bucchieri. 2022. "Does Intestine Morphology Still Have Secrets to Reveal? A Proposal about the “Ghost” Layer of the Bowel" Applied Biosciences 1, no. 1: 95-100. https://doi.org/10.3390/applbiosci1010006

Article Metrics

Back to TopTop